ACI 340B Management

340B manufacturer claims data requirements are expanding in 2026!

As of June, ten manufacturers have implemented or announced claims-level data submission requirements, creating new operational and compliance challenges for covered entities.

Covered entities should track effective dates, impacted products, required data fields, submission deadlines, state exemptions, vendor responsibilities, and internal data-sharing decisions.

Because each policy is manufacturer-specific, requirements should be reviewed individually before data is shared.

Stay current. Coordinate with vendors. Document decisions. Let ACI answer your questions.

Read more here: https://aci340b.com/340b-manufacturer-claims-data-requirements-2026/

This Memorial Day, ACI pauses to remember and honor the brave men and women who made the ultimate sacrifice in service to our country.

Their courage, dedication, and selflessness will never be forgotten.
As we spend time with family and friends this holiday weekend, we reflect with gratitude on the freedoms made possible by our fallen heroes.

Thank you to all who have served and sacrificed!

340B Landscape Update: Wins, Pressure & What’s Next

State contract pharmacy laws are gaining ground with major wins in Tennessee, Colorado, and Minnesota, while new reporting requirements and manufacturer policies continue to increase pressure on covered entities.

Key takeaways:
*Courts are siding with providers
* In-house reporting requirements are expanding
*PDABs could impact 340B savings
*Compliance complexity is growing

Staying informed isn’t optional, it’s essential!

Read more in our April newsletter: https://aci340b.com/aci-monthly-april-2026/